Express Scripts Offers New Value-Based Program for Migraine
Industry first SafeGuardRx Migraine Care Value Program Brings Affordability to Migraine Prevention and Treatment for Patients and Payers
Read MoreAsk the Pharmacist: After a Rare Disease Diagnosis, What’s Next?
On Rare Disease Day and every day, Accredo helps patients and caregivers manage complex conditions and therapies.
Read MoreExpress Scripts Offers Prescription Cost Relief for Newly Uninsured Americans
Unprecedented program convenes manufacturers and pharmacies to help millions of Americans access prescription medications at affordable and predictable prices.
Read MoreExpress Scripts Leads Industry with New HIV Prevention Program
The HIV Care ValueSM program, part of the company’s SafeGuardRx® platform, will drive value and improve cost predictability for employers, health plans, and people at risk for HIV.
Read MoreExpress Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program
In its first year, the Express Scripts Diabetes Care Value program delivered nearly $43 million savings for plans; reduced heart attack risk in 15 percent of patients
Read MoreExpress Scripts and Appriss Health Create New Military Health System Prescription Drug Monitoring Program
New Military Health System PDMP Closes Crucial Information Gap to Improve Safety of Controlled Substances for Military Members and their Families
Read MoreExpress Scripts Improves Patient Access to Digital Health Solutions
Future-focused formulary for digital health, medicine and therapeutics will allow employers and health plans to effectively manage a fast-growing segment of health care while improving access for pati...
Read MoreExpress Scripts' Innovative Advanced Opioid Management Solution Shifts First-Time Opioid Users to Safer, Short-Term Prescriptions
Read MoreNational Drug Purchasing Coalition and Express Scripts Team Up to Create New Pharmacy Benefit Design
Read MoreFDA Approved Drugs: January 2021
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in December 2020.
Read More